Evidence map›Paper›PMID 35799934›Full record

ArticleRSC advances2022

Pyridine appended 2-hydrazinylthiazole derivatives: design, synthesis,

Ramkishore Matsa, Parameshwar Makam, Guneswar Sethi, Ahammed Ameen Thottasseri, Aswani Raj Kizhakkandiyil, Krishna Ramadas, Vignesh Mariappan, Agieshkumar Balakrishna Pillai, Tharanikkarasu Kannan

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 23 citations in OpenAlex.

  1. Investigation of Potent Anti-Drug design, development and therapy · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Molecular Hybrids of Pyazolo[3,4-Molecules (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ramkishore MatsaDepartment of Chemistry, Pondicherry University Kalapet Puducherry 605 014 India tharani.che@pondiuni.edu.in.
Parameshwar MakamDr Param Laboratories Plot No. 478, BN. Reddy Nagar, Cherlapally Hyderabad Telangana 500 051 India.
Guneswar SethiCentre for Bioinformatics, Pondicherry University Puducherry 605 014 India.
Ahammed Ameen ThottasseriDepartment of Chemistry, Pondicherry University Kalapet Puducherry 605 014 India tharani.che@pondiuni.edu.in.ORCID https://orcid.org/0000-0003-0516-1770
Aswani Raj KizhakkandiyilDepartment of Chemistry, Pondicherry University Kalapet Puducherry 605 014 India tharani.che@pondiuni.edu.in.
Krishna RamadasCentre for Bioinformatics, Pondicherry University Puducherry 605 014 India.
Vignesh MariappanCentral Inter-Disciplinary Research Facility (CIDRF), Sri Balaji Vidyapeeth (Deemed to be University) Puducherry 607 402 India.
Agieshkumar Balakrishna PillaiCentral Inter-Disciplinary Research Facility (CIDRF), Sri Balaji Vidyapeeth (Deemed to be University) Puducherry 607 402 India.
Tharanikkarasu KannanDepartment of Chemistry, Pondicherry University Kalapet Puducherry 605 014 India tharani.che@pondiuni.edu.in.ORCID https://orcid.org/0000-0003-4426-983X
Pondicherry University · INSri Balaji Vidyapeeth University · INUttaranchal University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An array of pyridine appended 2-hydrazinylthiazole derivatives has been synthesized to discover novel chemotherapeutic agents for

Identifiers

PMID35799934
PMCPMC9215125
OpenAlexW4284960805

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.